Metropolitan Life Insurance Company (MetLife)’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,869
| Closed | -$49.3K | – | 2041 |
|
|
2024
Q1 | $49.3K | Hold |
4,869
| – | – | ﹤0.01% | 1410 |
|
|
2023
Q4 | $49K | Hold |
4,869
| – | – | ﹤0.01% | 1460 |
|
|
2023
Q3 | $45.6K | Buy |
4,869
+293
| +6% | +$2.75K | ﹤0.01% | 1454 |
|
|
2023
Q2 | $112K | Buy |
+4,576
| New | +$112K | 0.01% | 966 |
|
|
2023
Q1 | – | Sell |
-4,382
| Closed | -$111K | – | 2470 |
|
|
2022
Q4 | $111K | Hold |
4,382
| – | – | 0.01% | 994 |
|
|
2022
Q3 | $84.5K | Hold |
4,382
| – | – | ﹤0.01% | 1115 |
|
|
2022
Q2 | $112K | Buy |
4,382
+472
| +12% | +$12K | ﹤0.01% | 996 |
|
|
2022
Q1 | $101K | Sell |
3,910
-11,534
| -75% | -$297K | ﹤0.01% | 1188 |
|
|
2021
Q4 | $647K | Sell |
15,444
-827
| -5% | -$34.6K | 0.01% | 1253 |
|
|
2021
Q3 | $708K | Buy |
+16,271
| New | +$708K | 0.01% | 1203 |
|
|
2021
Q2 | – | Sell |
-15,024
| Closed | -$770K | – | 2889 |
|
|
2021
Q1 | $770K | Sell |
15,024
-667
| -4% | -$34.2K | 0.01% | 1133 |
|
|
2020
Q4 | $420K | Hold |
15,691
| – | – | 0.01% | 1470 |
|
|
2020
Q3 | $539K | Buy |
15,691
+1,477
| +10% | +$50.7K | 0.01% | 1164 |
|
|
2020
Q2 | $582K | Buy |
14,214
+11,715
| +469% | +$480K | 0.01% | 1088 |
|
|
2020
Q1 | $85.6K | Buy |
+2,499
| New | +$85.6K | ﹤0.01% | 2124 |
|